Companies / Colonai
Colonai
New York, United States
Colonai develops AI-powered software to help gastroenterologists efficiently screen, detect, and treat colorectal tumors during colonoscopy and capsule endoscopy.
Colonai, based in New York, United States, has 2 investors on file, among them Almaworks and Health Wildcatters. Its site was last checked 6 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Accelerator | |
| Portfolio page | Accelerator |
More from Almaworks
29 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (25%), AI & Machine Learning (20%), Education (13%).
More from Health Wildcatters
73 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (76%), AI & Machine Learning (4%), Enterprise Software (4%).
See Health Wildcatters' full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Colonai and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Almaworks adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/colonai.com/investors
# also
GET /v1/companies/colonai.com
GET /v1/companies/colonai.com/news